Abstract:OBJECTIVE:To investigate the effect of dendritic cells (DCs) pulsed by oligonucleotide containing "un-methylated cytimidine-phosphodiester bond-guanylic acid" motif (CpG ODN) on ovarian carcinoma cells. METHODS:Dendritic cells were isolated form the peripheral monocytes and co-incubated with synthesized CpG2006, CAI125, important epithelial ovarian cancer-associated antigen, or CpG ODN + CA125 for 72 h. Flow cytometry (FC) was used to detect the expression of CD(1alpha), CD(63), CD(86), and human leucocyte antigen-DR (HLA-DR) on the cell surface. ELISA was used to detect the IL-12 level in the supernatant. T cells were obtained from the DCs. The suspensions of different groups of pulsed DCs were co-incubated with T cells. Mixed lymphocyte reaction (MLR) was used to detect the proliferating activity of the T cells. Ovarian carcinoma cells of the line OVCAR-3 were added into the culture fluid of T cells with different effector-target ratios, and then unpulsed DCs, CpG ODN-pulsed DCs, CpG ODN + CA125-pulsed DCs, and CA125-pulsed DCs were added respectively. MTT colorimetry was performed to measure the A values of different wells so as to calculate the killing rate. RESULTS:(1) The expression levels of CD(63), CD(86), and HLA-DR on the membranes of the CpG ODN-pulsed DCs and CpG ODN + C125-pulsed DCs were significantly higher than those of the un-pulsed DCs (all P < 0.01), however, there were no significant differences in the expression of CD(1alpha) among different groups (all P > 0.05). (2) The IL-12 levels in the supernatants of the CpG ODN-pulsed DCs and CpG ODN + C125-pulsed DCs were significantly higher than those of the unpulsed and CA125-pulsed groups (all P < 0.01). (3) MLR showed that the T cell proliferation rates of the T cells sensitized by the CpG ODN-pulsed DCs and CpG ODN + C125-pulsed DCs were both higher than those of the T cells stimulated by the unpulsed and CA125-pulsed groups when the effector: target ratio was 10:1 (all P < 0.01). (4) The killing rates on OVCAR-3 cells of the CTLs sensitized by CpG ODN + CA125-pulsed DCs at the same effector: target ratios were all higher than those of the CTLs sensitized by the CpG ODN-pulsed DCs, CA125-pulsed DCs, and unpulsed DCs (all P < 0.01), the killing activity of the cytotoxic T lymphocytes (CTLs) sensitized by CpG ODN+CA125-pulsed DCs on the OVCAR-3 cells was shown even when the effector: target ratio was as low as 10:1, and then increased along with the increase of the effector: target ratio to the height of 64.9%. CONCLUSION:Capable of inducing immune cytotoxicity on ovarian carcinoma, DCs sensitized by CpG ODN + CA125 may have a great implication on clinical application.

Establishment of Specific Cytotoxic T Lymphocyte Culture System and Its Inhibitory Effect on Ovarian Cancer

Establishment and identification of specific cytotoxic T lymphocyte in vitro culture system and the effect on ovarian cancer cells

Ovarian Carcinoma Cell Supernatants Inhibit Proliferation and IL-2R Expression of CD8~+ T Cell

Anti-tumor Effect and Its Antigenic Specificity of Cytotoxicity T Lymphocytes Induced by SKOV3 Ovarian Carcinoma Cell Line Freeze-thaw Antigen

In vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigen

Ovarian caremoma cell supernatants inhibit proliferation and IL-2R expression of CD8+ T cell

Cytotoxicity of peripheral blood lymphocyte-mediated by an anti-human ovarian carcinoma-anti-human CD3 bispecific single-chain antibody(BHL-I)in vitro and its mechanisms

Conversion of Peripheral CD4+ CD25- Naive T Cells to CD4+ CD25+ Regulatory T Cells by Ovarian Carcinoma Cell Supernatants

Effect of Cytokine-induced Killer Cells on the Drug Resistance of Ovarian Cells

Low Molecular Weight Fraction Secreted by SKOV3 Cells Expands Peripheral CD4+CD25+ Regulatory T Cells and Enhances Their Suppressive Capacity

Human Epithelial Ovarian Carcinoma Cell-Derived Cytokines Cooperatively Induce Activated Cd4+Cd25-Cd45ra+Naive T Cells To Express Forkhead Box Protein 3 And Exhibit Suppressive Ability In Vitro

Ovarian Carcinoma Cells Inhibit T Cell Proliferation: Suppression of IL-2 Receptor Β and Γ Expression and Their JAK-STAT Signaling Pathway

Human Ovarian Cancer Stem-Like Cells Can Be Efficiently Killed by Γδ T Lymphocytes

Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine

[Cytotoxicity of Dendritic Cells Pulsed by CpG ODN on Ovarian Carcinoma Cells: in Vitro Experiment with Ovarian Carcinoma Cells].

Synergistic cytotoxicity of interferonalpha-2b and interleukin-2 in combination with PBMC against ovarian cancer: development of an experimental model for cellular therapy

The anti-tumor effects of CIK against ovarian cancer cell lines SKOV-3 in vitro

Study on the phenotype and function of CD8+Treg cells induced by ovarian cancer cell

Inhibitory Effect of Ginsenoside Rg3 Combined with Cyclophosphamide on Growth and Angiogenesis of Ovarian Cancer

[Establishment of the Culture System of Γδ T Cells in Vitro and the Anti-Tumor Effect].

Effect of Cytokine-induced Killer Cells Combined with Cisplatin Chemotherapy in Patients with Malignant Ovarian Tumor